A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings

Journal of NeuroVirology

Volumn 17, Issue 5, 2011, Pages 438-447

  Robertson, Kevin ^a,m   Kumwenda, Johnstone ^b   Supparatpinyo, Khuanchai ^c   Jiang, Jeanne H ^d   Evans, Scott ^d   Campbell, Thomas B ^e   Price, Richard W ^f   Murphy, Robert ^g   Hall, Colin ^a   Marra, Christina M ^h   Marcus, Cheryl ^a   Berzins, Baiba ^g   Masih, Reena ⁱ   Santos, Breno ^b   Silva, Marcus T ^j   Kumarasamy, N ^b   Walawander, Ann ^k   Nair, Apsara ^k   Tripathy, Srkanth ^b   Kanyama, Cecilia ^b   Hosseinipour, Mina ^b   Montano, Silvia ^b   La Rosa, Alberto ^b   Amod, Farida ^b   Sanne, Ian ^b   Firnhaber, Cindy ^b   Hakim, James ^b   Brouwers, Pim ^l   more..

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Queen Elizabeth ^*

^c CHIANG MAI UNIVERSITY   (Thailand)

^d HARVARD UNIVERSITY   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^j INSTITUTO OSWALDO CRUZ   (Brazil)

^k FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^l NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^m UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

more..

Author keywords

CNS; Cognitive impairment; HIV; Neuropsychological examination; Resource limited

Indexed keywords

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIA; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYNEUROPATHIES; PREVALENCE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOUTH AMERICA; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84856137520     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-011-0044-3     Document Type: Article

References (31)

1. Affandi JS, Price P, Imran D, Yunihastuti E, Djauzi S, Cherry CL (2008) Can we predict neuropathy risk before stavudine prescription in a resource-limited setting? AIDS Res Hum Retroviruses 24(10):1281-1284
2. American Academy of Neurology (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41(6):778-785
3. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789-1799 (Pubitemid 350059308)
4. Belec L, Martin PMV, Vohito MD, Gresenguet G, Tabo A, Georges AJ (1989) Low prevalence of neuropsychiatric clinical manifestations in central African patients with acquired immune deficiency syndrome. Trans R Soc Trop Med Hyg 83:844-846 (Pubitemid 20004507)
5. Elder GA, Sever JL (1988) AIDS and neurological disorders: an overview. Ann Neurol 23:S4-S6
6. Gendleman H, Zheng J, Coulter C, Ghorpade A, Che M, Thylin M, Rubocki R, Persidsky Y, Hahn F, Reinhard J, Swindells S (1998) Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in HIV associated dementia. J Infect Dis 178:1000-1007 (Pubitemid 28452191)
7. Grey P, Berger P (2007) Pain in women with HIV/AIDS. Pain 132(Suppl 1):S13-S21 (Pubitemid 350027781)
8. Howlett WP, Nkya WM, Mmni KA, Missalek WR (1989) Neurological disorders in AIDS and HIV disease in the northern zone of Tanzania. J AIDS 3:289-296 (Pubitemid 19167471)
9. Jowi JO, Mativo PM, Musoke SS (2007) Clinical and laboratory characteristics of hospitalised patients with neurological manifestations of HIV/AIDS at the Nairobi hospital. East Afr Med J 84(2):67-76
10. Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenal B, Lai AR, Saghayam S, Balakrishnan P, Yepthomi T, Poongulali S, Flanigan TP, Solomon S, Mayer KH (2008) Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients. AIDS Patient Care STDS 22(4):337-344 (Pubitemid 351562965)
11. Maj M, Satz P, Janssen R, Zaudig M, Starace F, D'Elia L, Sughondhabirom B, Mussa M, Naber D, Ndetei D, Schulte G, Sartorius N (1994) WHO Neuropsychiatric AIDS study, crosssectional phase II. neuropsychological and neurological findings. Arch Gen Psych 51(1):51-61 (Pubitemid 24028998)
12. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP, Visscher BR, Concha M, Saah A (1993) Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43(11):2245-2252 (Pubitemid 23346956)
13. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N (2003) HIVassociated dementia: A evolving disease. J Neurovirol 9:205-221
14. Mielke J (2005) Neurological complications of human immunodeficiency virus infection in Zimbabwe-2005. J Neurovirol 11 (Suppl 3):23-25
15. Navia BA, Cho ES, Petito CK, Price RW (1986a) The AIDS dementia complex: neuropathology. Ann Neurol 19:525-535
16. Navia BA, Jordan BD, Price RW (1986b) The AIDS dementia complex: I. clinical features. Ann Neurol 19:517-524 (Pubitemid 16085185)
17. Parry O, Mielke J, Latif AS, Ray S, Levy LF, Siziya S (1997) Peripheral neuropathy in individuals with HIV infection in Zimbabwe. Acta Neurol Scand 96(4):218-222 (Pubitemid 27402489)
18. Price RW, Sidtis JJ (1990) Evaluation of the AIDS Dementia Complex in clinical trials. J AIDS 3(Suppl 2):S51-S60
19. Price RW, Spudich SJ (2008) Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis 197(Supp 3):S294-S306 (Pubitemid 351717319)
20. Robertson KR, Hall CD (1992) HIV related mild cognitive impairment and AIDS dementia complex. Semin Neurol 12(1):18-27
21. Robertson KR, Robertson W, Ford S, Watson D, Fiscus S, Harp A, Hall C (2004) Highly active antiretroviral therapy improves neurocognitive function. J AIDS 36(1):562-566 (Pubitemid 38544504)
22. Sacktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8 (Suppl 2):115-121 (Pubitemid 36097787)
23. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes O, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, Marcaida J, Cohen B, Epstein L (2002) HIV-1 associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8(2):136-142 (Pubitemid 34520894)
24. Sacktor N, Nakasujja N, Skolasky RL, Rezapour M, Robertson K, Musisi S, Katabira E, Ronald A, Clifford DB, Laeyendecker O, Quinn TC (2009) HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 49(5):780-786
25. Schifitto G, Kieburtz K, McDermott M, McArthur J, Marder K, Sacktor N, Palumbo D, Selnes O, Stern Y, Epstein L, Albert S (2001) Clinical Trials in HIV associated cognitive impairment: Cognitive and functional domains. Neurology 56:415-418 (Pubitemid 32144162)
26. Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, McClernon DR, Conant K, Cohen B, Epstein LG, Kieburtz K (2005) Markers of immune activation and viral load in HIV-associated sensory neuropathy. Neurology 64(5):842-828
27. Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K, Simpson D, Koch M, Feinberg J, Dafni U (1993) Zidovudine treatment of the AIDS dementia complex: results of a placebo controlled trial. AIDS Clinical Trials Group. Ann Neurol 33:343-349 (Pubitemid 23103965)
28. Simpson DM, Kitch D, Evans SR, McArthur JC, Asmuth DM, Cohen B, Goodkin K, Gerschenson M, So Y, Marra CM, Diaz-Arrastia R, Shriver S, Millar L, Clifford DB (2006) HIV neuropathy natural history cohort study. Neurology 66:1679-1687
29. Tozzi V, Balestra P, Galgani S, Murri R, Bellagamba R, Narciso P, Antinori A, Giulianeli M, Tosi G, Costa M, Sampaolesi A, Fantoni M, Noto P, Ippolito G, Wu A (2004) Neurocognitive performance and quality of life in patients with HIV infection. AIDS Human Retrovir 19(8):643-652
30. UNAIDS (2010) Global report: report on the global AIDS epidemic 2010
31. Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffam S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, Dwyer R, McCormack G, Hellard M, Cherry C, McArthur J, Wesselingh S (2008) Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology 71(1):50-56